Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli

Escherichia coli from Italy Producing OXA-48 Carbapenemase Encoded by a Novel Tn1999Transposon Derivative

(2012) Tommaso Giani et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A call for action

(2012) Patrice Savard et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype

(2012) James R. Johnson et al.   INFECTION AND IMMUNITY

Fourteen years in resistance

(2012) David M. Livermore   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48

(2011) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings

(2011) G. Croxall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England

(2011) T. M. Gibreel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Effects of single and multiple pathogenicity island deletions on uropathogenic Escherichia coli strain 536 intrinsic extra-intestinal virulence

(2010) Jérôme Tourret et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains

(2008) Françoise Jaureguy et al.   BMC GENOMICS